K, E. - G., E. - G. A, S. S, and M. H, "Juvenile dermatomyositis: demographics, characteristics and disease outcome in an Egyptian cohort", Clin Exp Rheumatol, vol. 40, issue 2, pp. 450-56, 2022.
El-Garf, A., M. Abdo, A. Alkemary, and S. Mohamed, "Behcet’s disease patterns and subsets in a cohort of Egyptian patients", The Egyptian Rheumatologist (Elsevier) , vol. 41, issue 2, pp. 135-138, 2019.
El-Garf, A., R. Gheith, and S. Badran, "clinical pattern in Egyptian systemic lupus erythematosus patients with pleuropulmonary involvement.", The Egyptian Rheumatologist (Elsevier) , vol. 39, issue 2, pp. 83-88, 2017.
El-Garf, K., huda marzouk, yomna farag, L. Rasheed, and A. El-Garf, "Mean platelet volume is a marker of inflammation but not a marker of disease activity in children with juvenile SLE", The Egyptian Rheumatologist (Elsevier), vol. 38, pp. 35-39, 2016.
Halabi, H., A. Alarfaj, K. Alawneh, S. Alballa, K. Alsaeid, H. Badsha, R. Benitha, E. Bouajina, S. A. Emadi, A. El-Garf, et al., "Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and Middle East", Int J Rheum Dis, vol. 18, issue 3, pp. 268-75, 2015. Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and Middle East.pdf
Bedaiwi, M., A. brahim Al‑Homood, A. El‑Garf, E. Uthman, N. Sunna, R. Nassier, H. Mohamed, and J. Al Saleh, "Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East", Rheumatology International, vol. 39, pp. 1321-1329, 2019.
El-Garf, A., A. Shahin, S. Fawzy, S. Shawky, M. Azim, D. Effat, and S. AbdelRahman, "Efficacy of infliximab in refractory posterior uveitis in Behcet’s disease patients", The Egyptian Rheumatologist (Elsevier) , vol. 40, issue 2, pp. 93-97, 2018.
El-Garf, K., huda marzouk, yomna farag, L. Rasheed, and A. El-Garf, "Mean platelet volume is a marker of inflammation but not a marker of disease activity in children with juvenile SLE", The Egyptian Rheumatologist (Elsevier) , vol. 38, pp. 35-39, 2016.
El-Garf, A., S. Fawzy, F. Talaat, and M. abd elaziz, "Efficacy and safety of combined pegylated interferon/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients", The Egyptian Rheumatologist (Elsevier) , vol. 38, pp. 53-59, 2016.